These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10828759)

  • 1. Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.
    Bos H; Andersen S; Rossing P; De Zeeuw D; Parving HH; De Jong PE; Navis G
    Kidney Int Suppl; 2000 Apr; 75():S32-7. PubMed ID: 10828759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.
    de Jong PE; Heeg JE; Apperloo AJ; de Zeeuw D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S28-32. PubMed ID: 1382162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.
    Heeg JE; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D; Minutolo R; Pisani A; Esposito R; Signoriello G; Andreucci M; Balletta MM
    Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
    Laverman GD; Navis G; Henning RH; de Jong PE; de Zeeuw D
    Kidney Int; 2002 Sep; 62(3):1020-5. PubMed ID: 12164886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease.
    Shiigai T; Shichiri M
    Am J Kidney Dis; 2001 Mar; 37(3):477-83. PubMed ID: 11228170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
    Vogt L; de Zeeuw D; Woittiez AJ; Navis G
    Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
    Gansevoort RT; Sluiter WJ; Hemmelder MH; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1995 Nov; 10(11):1963-74. PubMed ID: 8643149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.
    Titan SM; M Vieira J; Dominguez WV; Barros RT; Zatz R
    Clin Nephrol; 2011 Oct; 76(4):273-83. PubMed ID: 21955862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.
    Heeg JE; de Jong PE; Vriesendorp R; de Zeeuw D
    Am J Nephrol; 1990; 10 Suppl 1():94-7. PubMed ID: 2175149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.